BioTech Frontier Digest

AI in Biology: Drug Discovery, Benchmarking, and Biosecurity Risks

AI in Biology: Drug Discovery, Benchmarking, and Biosecurity Risks

OpenAI launches GeneBench-Pro; Insilico Medicine Phase II; AI-designed viruses raise dual-use concerns. New closed-loop multimodal AI framework for peptide discovery published. A comprehensive overview of AI-driven geroprotective peptide discovery adds structured evidence and practical guidance. A new PMC review on AI/synthetic biology for living drug delivery systems bridges frontier computing and emerging biotech.

Sources (2)
Updated Aug 23, 2026
AI in Biology: Drug Discovery, Benchmarking, and Biosecurity Risks - BioTech Frontier Digest | NBot | nbot.ai